...
首页> 外文期刊>Neurological Research: An Interdisciplinary Quarterly Journal >Atorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory properties
【24h】

Atorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory properties

机译:阿托伐他汀可能通过其抗氧化剂和抗炎特性具有脂肪肝诱导的脂肪肝诱导的记忆功能障碍的治疗潜力

获取原文
获取原文并翻译 | 示例

摘要

This study aimed to evaluate the memory function in a rat model of fatty liver and to investigate the effects of statins on fatty liver, neuronal inflammation, oxidative stress and memory. In this study, 24 male rats were used and were divided into four groups consisting of 6 animals in each. Of them, 12 rats received liquid diet containing 35% fructose for 8 weeks in order to induce hepatosteatosis, while other animals had a normal nutrition. Group 1 served as controls and had a normal nutrition with no drug treatment. The animals in Group 2 had a normal nutrition and treated with atorvastatin. Group 3 received high-fructose diet with no drug treatment and Group 4 received high-fructose diet followed by atorvastatin treatment. After the two weeks of treatment period, passive avoidance tasks evaluating the memory were performed in both the study and control groups. The liver and brain were then removed for histologic, pathologic, and biochemical evaluation. In the non-treated rats with hepatosteatosis (Group 3), the lowest mean latency time and the highest mean histopathologic liver score, and brain TNF- alpha and MDA (Measurement of lipid peroxidation) were found (p < 0.00001). On the other hand, in the animals treated with atorvastatin, all these parameters were significantly higher than that of controls and significantly lower than that of Group 3 (p < 0.05). Fatty liver can increase inflammation and cause memory disorders, and atorvastatin may have a positive effect on cognitive disorders.
机译:本研究旨在评估脂肪肝大鼠模型中的记忆功能,并研究他汀类药物对脂肪肝,神经元炎症,氧化应激和记忆的影响。在这项研究中,使用了24只雄性大鼠,分为四组,每组6种动物。其中,12只大鼠含有35%果糖的液体饮食8周,以诱导肝胃蛋白,而其他动物具有正常的营养。第1组用作对照,没有药物治疗的正常营养。第2组的动物具有正常的营养并用阿托伐他汀治疗。第3组接受了高果糖饮食,没有药物治疗,第4组接受高果糖饮食,然后接着过量脱落素治疗。在治疗期间两周后,在研究和对照组中进行评估存储器的被动避免任务。然后除去肝脏和大脑用于组织学,病理和生化评估。在具有肝胃蛋白酶的未处理的大鼠(第3组)中,发现最低平均潜伏时间和最高平均组织病理学肝脏评分,以及脑TNF-α和MDA(脂质过氧化的测量)(P <0.00001)。另一方面,在用阿托伐他汀治疗的动物中,所有这些参数明显高于对照的,显着低于第3组(P <0.05)。脂肪肝可以增加炎症并引起记忆障碍,阿托伐他汀可能对认知疾病产生积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号